Browse > Article
http://dx.doi.org/10.6114/jkood.2022.35.3.114

A Case Report of Abducens Nerve Palsy after Cancer Immunotherapy Treated with Korean Medicine  

Kim, Jae-Ho (Dep. of Ophthalmology, Otolaryngology and Dermatology of Korean Medicine, Kyung Hee University Hospital at Gangdong)
Ko, Hye-Yeon (Dep. of Ophthalmology, Otolaryngology and Dermatology of Korean Medicine, Kyung Hee University Hospital at Gangdong)
Kim, Min-Hee (Dep. of Ophthalmology, Otolaryngology and Dermatology of Korean Medicine, Kyung Hee University Hospital at Gangdong)
Publication Information
The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology / v.35, no.3, 2022 , pp. 114-122 More about this Journal
Abstract
Objective : The purpose of this study is to report the effect of Korean medicine treatments of abducens nerve palsy after cancer immunotherapy. Methods : A 63-year-old male patient who was suffering hepatocellular carcinoma had left eye abduction restriction, diplopia, and decreased visual acuity after taking 5th cancer immunotherapy(atezolizumab + bevacizumab). Western medicine was administered for 3 weeks, but there was no response. The patient was treated with herbal medicine, acupuncture, electroacupuncture, moxibustion and bee venom pharmacoacupuncture for 4 weeks. Result : The patient's eye abduction restriction and diplopia were resolved. Visual acuity was improved from NRS(Numerical Rating Scale) 8 to NRS 2. The patient continued immunotherapy and there was no worsening of symptoms. No adverse events were observed. Conclusions : This study shows that Korean medicine treatments were effective on abducens nerve palsy after cancer immunotherapy.
Keywords
Abducens nerve palsy; Cancer immunotherapy; Korean medicine;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Kim HS, Kim HM, Sung GJ, Yoo YS. Ophthalmology. 11th rev. ed. Seoul:Ilchokak. 2017:366-9.
2 Vogrig A, Muniz-Castrillo S, Joubert B, Picard G, Rogemond V, Skowron F, et al. Cranial Nerve Disorders Associated With Immune Checkpoint Inhibitors. Neurology. 2021;96(6):e866-75.   DOI
3 Scott AB, Kraft SP. Botulinum toxin injection in the management of lateral rectus paresis. Ophthalmology. 1985;92:676-83.   DOI
4 Jeong JS, Ryu BH, Kim JS, Park JW, Choi WC, Yoon SW. Bojungikki-Tang for Cancer-Related Fatigue: A Pilot Randomized Clinical Trial. Integr Cancer Ther. 2010;9(4):331-8.   DOI
5 Chung JWY, Yan VCM, Zhang H. Effect of Acupuncture on Heart Rate Variability: A Systematic Review. Evid Based Complement Alternat Med. 2014;2014:1-19.
6 Hideaki W, Tatsuya H, Shogo M, Naruto Y, Hideaki T, Yoichi M, et al. Effect of 100 Hz electroacupuncture on salivary immunoglobulin A and the autonomic nervous system. Acupunct Med. 2015;33(6):451-6.   DOI
7 Sheng Y, Zhu L. The crosstalk between autonomic nervous system and blood vessels. Int J Physiol Pathophysiol Pharmacol. 2018;10(1):17-28.
8 Wang L, Zhang Y, Wang W, Ye Z. Electroacupuncture-induced cannabinoid receptor expression in repair of abducens nerve. Int J Neurosci. 2019;129(9):923-9.   DOI
9 Fei J, Gao L, Li HH, Yuan QL, Li LJ. Electroacupuncture Promotes Peripheral Nerve Regeneration after Facial Nerve Crush Injury and Upregulates the Expression of Glial Cell-Derived Neurotrophic Factor. Neural Regen Res. 2019;14(4):673-82.   DOI
10 Kimura K, Takeuchi H, Yuri K, Wakayama I. Inhibition of Nitric Oxide Synthase Attenuates Cutaneous Vasodilation During Warm Moxibustion-Like Thermal Stimulation in Humans. J Altern Complement Med. 2012;18(10):965-70.   DOI
11 Yoo HJ, Kim GJ. Analysis of Pharmacopuncture Used in Facial Nerve Palsy Articles that Published in the Journal of Korean Medicine. J Korean Med Ophthalmol Otolaryngol Dermatol. 2019; 32(3):105-15.   DOI
12 Di Z, Guo Q, Zhang Q. Neuroprotective Effect of Moxibustion on Cerebral Ischemia/ Reperfusion Injury in Rats by Downregulating NR2B Expression. Evid Based Complement Alternat Med. 2021;2021:1-10.
13 Tender T, Rahangdale RR, Balireddy S, Nampoothiri M, Sharma KK, Chandrashekar HR. Melittin, a honeybee venom derived peptide for the treatment of chemotherapy-induced peripheral neuropathy. Medical Oncology. 2021;38(5):1-9.   DOI
14 Han ER, Lim KH. Clinical features of the sixth cranial nerve palsy. J Korean Ophthalmol soc. 2008;49(8):1323-9.   DOI
15 Park UC, Kim SJ, Hwang JM, Yu YS. Clinical features and natural history of acquired third, fourth, and sixth cranial nerve palsy. Eye. 2008;22(5):691-6.   DOI
16 Tamhankar MA, Biousse V, Ying GS, Prasad S, Subramanian PS. Lee MS, et al. Isolated third, fourth, and sixth cranial nerve palsies from presumed microvascular versus other causes: a prospective study. Ophthalmology. 2013;120(11):2264-9.   DOI
17 Mikami T, Liaw B, Asada M, Niimura T, Zamami Y, Green-LaRoche D, et al. Neuroimmunological adverse events associated with immune checkpoint inhibitor: a retrospective, pharmacovigilance study using FAERS database. J Neurooncol. 2021;152(1):135-44.   DOI
18 Momeni M, Veras L, Zakashansky K. Bevacizumab-induced transient sixth nerve palsy in ovarian cancer: A case report. Asia Pac J Clin Oncol. 2016;12(1):e196-8.   DOI
19 Thomas C, Dawood S. Cranial nerve VI palsy (Abducens nerve). Disease-a-Month. 2021;67(5):1-5.
20 Jung EH, Kim SJ, Lee JY, Cho BJ. The incidence and etiology of sixth cranial nerve palsy in Koreans: A 10-year nationwide cohort study. Sci Rep. 2019;9(1):1-7.   DOI
21 The Society of Korean Medicine Ophthalmology, Otolaryngology & Dermatology. Korean Medicine Ophthalmology & Otolaryngology(Ophthalmology). 1st ed. Paju:Globooks. 2019:193,194.
22 Won SY, Kim MJ, Cha JY, Jung ES, Cho HK, Yoo HR, et al. Systematic Review of Korean Medicine for the Treatment of Sixth Cranial Nerve Palsy. J. Int. Korean Med. 2019;40 (3):409-24.   DOI
23 Azarmina M, Azarmina H. The Six Syndromes of the Sixth Cranial Nerve. J Ophthalmic Vis Res. 2013;8(2):160-71.
24 Elder C, Hainline C, Galetta SL, Balcer LJ, Rucker JC. Isolated Abducens Nerve Palsy: Update on Evaluation and Diagnosis. Curr Neurol Neurosci Rep. 2016;16(8):1-7.   DOI
25 Gordan JD, Kennedy EB, Abou-Alfa GK, Beg MS, Brower ST, Dade TP, et al. Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline. J Clin Oncol. 2020;38(36):4317-45.   DOI
26 Ministry of Health and Welfare. 2022[cited 2022 Jul 17]. Available from:URL:https://www.mohw.go.kr/react/al/sal0301vw.jsp?PAR_MENU_ID=04&MENU_ID=0403&page=1&CONT_SEQ=371344
27 Jaben KA, Francis JH, Shoushtri AN, Abramson DH. Isolated Abducens Nerve Palsy Following Pembrolizumab. Neuroophthalmology. 2020;44(3):182-5.   DOI
28 Zimmer L, Goldinger SM, Hofmann L, Loquai C, Ugurel S, Thomas I, et al. Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy. Eur J Cancer. 2016;60:210-25.   DOI
29 Park SG, Kim YG, Oh MS. Prescriptionology. 1st ed. Seoul:Yeonglimsa. 2017:195,196.
30 Kung NH, Stavern GP. Isolated Ocular Motor Nerve Palsies. Semin Neurol. 2015;35(5):539-48.   DOI
31 National Oriental Medicine College Collaborative Textbook Compilation Committee. Herbalogy. 3rd ed. Seoul: Yeonglimsa. 2011:593.